AtriCure (ATRC) Reports In-Line Q4 EPS

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to AtriCure (ATRC) Reports In-Line Q4 EPS

AtriCure Reports Fourth Quarter and Full Year 2015 Financial Results

February 23, 2016 4:00 PM EST

2015 revenue of $129.8 million up 20.8% as reported, 23.8% constant currency 2015 U.S. sales of $102.2 million up 27.4% Fourth quarter 2015 revenue of $35.9 million up 21.9% as reported, 24.0% constant currency

MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced fourth quarter and full year 2015 financial results.

We are pleased to report strong 2015 results, positioning us well in 2016 as we continue to execute on delivering our portfolio of innovative solutions for atrial... More